TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones07-31

DJ TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.78% to 25,122.18 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.

TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th.

Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 2.24% to $257.41.

Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795.

Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2655811133?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 05:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655811133","market":"fut","top_or_hot":-1,"title":"TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/TXMD\">TherapeuticsMD Inc.</a> Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.78% to 25,122.18 and the Dow Jones Industrial Average  rising 1.19% to 52,208.06. \n</p>\n<p>\n     TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> fell 2.24% to $257.41. \n</p>\n<p>\n     Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses on the Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-31 05:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/TXMD\">TherapeuticsMD Inc.</a> Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.78% to 25,122.18 and the Dow Jones Industrial Average  rising 1.19% to 52,208.06. \n</p>\n<p>\n     TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. <a href=\"https://laohu8.com/S/ABBV\">$(ABBV)$</a> fell 2.24% to $257.41. \n</p>\n<p>\n     Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXMD","symbol_name":"TherapeuticsMD Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2655811133","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655811133","pubTimestamp":1785447060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"TXMD":"TherapeuticsMD Inc."},"translate_title":"尽管当天亏损，TherapeuticsMD Inc. 股票仍跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXMD":1.5},"content_text":"DJ TherapeuticsMD Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.78% to 25,122.18 and the Dow Jones Industrial Average  rising 1.19% to 52,208.06. \n\n\n     TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th. \n\n\n     Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 2.24% to $257.41. \n\n\n     Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2655811133","isCrawlerRequest":true}